TUESDAY, Sept. 21, 2021 (HealthDay News) — After a stroke, the best time to work on regaining hand and arm use is 60 to 90 days later, according to a new clinical trial. Starting intensive rehab at less than 30 days can be helpful, too, but waiting until six monthsContinue Reading
TUESDAY, Sept. 21, 2021 (HealthDay News) — Potentially dangerous symptoms of type 1 diabetes in children are not always immediately recognized by primary care providers, new research suggests. In type 1 diabetes, the pancreas fails to make enough insulin, the hormone that helps regulate blood sugar used for energy byContinue Reading
TUESDAY, Sept. 21, 2021 (HealthDay News) — After more than a year at home, children are heading back to classrooms across the country. But they’re also toting heavy bags on their backs again. A backpack that fits properly — and is not overloaded with binders and books — will helpContinue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) — New research offers good news for women with an aggressive HER2-positive breast cancer. A targeted therapy, trastuzumab deruxtecan (T-DXd), sold as Enhertu, triples the length of time that the cancer remains in check when compared with the current gold standard, trastuzumab emtansine (T-DM1).Continue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) — Millions of U.S. sleep apnea patients are scrambling to find ways to protect their nightly slumber, following a voluntary recall from one of the nation’s leading manufacturers of CPAP breathing machines. Philips Respironics agreed to a voluntary recall of continuous positive airway pressureContinue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) — Starting in November, the United States plans to lift travel restrictions on people coming from overseas who are fully vaccinated against COVID-19. This move by the Biden administration will open the United States to relatives separated from families as well as business travelers.Continue Reading
Here are some of HealthDay’s top stories for Monday, Sept. 20: Lower dose of Pfizer vaccine works in kids as young as 5: The pharmaceutical giant announced Monday that a dose that is one-third the strength of adult doses triggered a robust immune response in young children. Read more GoodContinue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) — A smaller dose of Pfizer’s coronavirus vaccine safely triggers a strong immune response in children as young as 5, the company announced Monday morning. “Over the past nine months, hundreds of millions of people ages 12 and older from around the world haveContinue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) — If a person is diagnosed with COVID-19 in the United States right now, it’s almost certainly caused by the Delta variant. The highly transmissible variant, which caused crippling surges in India and Britain this past spring and fueled case spikes in the UnitedContinue Reading
MONDAY, Sept. 20, 2021 (HealthDay News) – If Americans who received the Moderna or Johnson & Johnson coronavirus vaccines are dismayed by the lack of information on booster shots for them, their wait should end soon. Data on booster shots for those vaccines is only a few weeks away fromContinue Reading